ICU Medical, Inc. (ICUI) Tops Q2 EPS by 4c; Narrows FY12 Outlook
ICU Medical, Inc. (NASDAQ: ICUI) reported Q2 EPS of $0.63, $0.04 better than the analyst estimate of $0.59. Revenue for the quarter came in at $77.3 million versus the consensus estimate of $77.98 million.
ICU Medical, Inc. sees FY2012 EPS of $2.55-$2.70, versus prior guidance of $2.45-$2.70 and the consensus of $2.58. ICU Medical, Inc. sees FY2012 revenue of $318-$325 million, versus prior guidance of $318-$330 million and the consensus of $321.3 million.
For earnings history and earnings-related data on ICU Medical, Inc. (ICUI) click here.
ICU Medical, Inc. sees FY2012 EPS of $2.55-$2.70, versus prior guidance of $2.45-$2.70 and the consensus of $2.58. ICU Medical, Inc. sees FY2012 revenue of $318-$325 million, versus prior guidance of $318-$330 million and the consensus of $321.3 million.
For earnings history and earnings-related data on ICU Medical, Inc. (ICUI) click here.